DGX vs. JNJ
DGX (Quest Diagnostics Incorporated) and JNJ (Johnson & Johnson) are both stocks. Both are in the Healthcare sector — DGX in Diagnostics & Research, JNJ in Drug Manufacturers - General. Over the past 10 years, DGX returned 12.79%/yr vs 10.44%/yr for JNJ. Their 0.31 correlation means their historical movements had little consistent relationship.
Performance
DGX vs. JNJ - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, DGX achieves a 36.03% return, which is significantly higher than JNJ's 25.25% return. Over the past 10 years, DGX has outperformed JNJ with an annualized return of 12.79%, while JNJ has yielded a comparatively lower 10.44% annualized return.
DGX
- 1D
- -0.55%
- 1M
- 8.45%
- 6M
- 25.64%
- YTD
- 36.03%
- 1Y
- 38.78%
- 3Y*
- 22.45%
- 5Y*
- 12.61%
- 10Y*
- 12.79%
- ALL TIME*
- 16.17%
JNJ
- 1D
- 0.21%
- 1M
- -2.54%
- 6M
- 14.06%
- YTD
- 25.25%
- 1Y
- 57.03%
- 3Y*
- 18.33%
- 5Y*
- 11.37%
- 10Y*
- 10.44%
- ALL TIME*
- 12.28%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $320.44M | $243.98M | $192.25M | |
| $2.09B | $2.09B | $1.99B |
DGX vs. JNJ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
DGX Quest Diagnostics Incorporated | 36.03% | 17.20% | 11.77% | -10.05% | -7.80% | 47.86% | 14.11% | 31.13% | -13.84% | 9.16% |
JNJ Johnson & Johnson | 25.25% | 47.48% | -4.81% | -8.58% | 5.97% | 11.44% | 10.82% | 16.22% | -5.13% | 24.43% |
Correlation
The correlation between DGX and JNJ is 0.39, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.39 |
Correlation (3Y) Balances recent behavior with more history. | 0.43 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.42 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.37 |
Correlation (All Time) Calculated using the full available price history since Dec 26, 1996 | 0.31 |
The correlation between DGX and JNJ shifts across timeframes, from 0.31 (all time) to 0.43 (3 years), reflecting how their relationship changes across market environments.
Fundamentals
DGX:
$25.72B
JNJ:
$617.78B
DGX:
$9.46
JNJ:
$8.63
DGX:
24.63
JNJ:
29.71
DGX:
2.26
JNJ:
6.38
DGX:
3.47
JNJ:
7.36
DGX:
$11.56B
JNJ:
$97.93B
DGX:
$3.83B
JNJ:
$68.99B
DGX:
$2.01B
JNJ:
$31.92B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DGX vs. JNJ — Risk / Return Rank
DGX
JNJ
DGX vs. JNJ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Quest Diagnostics Incorporated (DGX) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| DGX | JNJ | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.50 | ||
| Sortino ratioReturn per unit of downside risk | -1.55 | ||
| Omega ratioGain probability vs. loss probability | 1.33 | 1.56 | -0.23 |
| Calmar ratioReturn relative to maximum drawdown | 3.62 | 5.46 | -1.84 |
| Martin ratioReturn relative to average drawdown | 7.81 | 15.18 | -7.37 |
Loading charts...
Drawdowns
DGX vs. JNJ - Drawdown Comparison
The maximum DGX drawdown since its inception was -49.46%, roughly equal to the maximum JNJ drawdown of -50.67%. Use the drawdown chart below to compare losses from any high point for DGX and JNJ.
Loading charts...
Drawdown Indicators
| DGX | JNJ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -49.46% | -50.67% | +1.21% |
Max Drawdown (1Y)Largest decline over 1 year | -11.55% | -10.96% | -0.59% |
Max Drawdown (3Y)Largest decline over 3 years | -12.44% | -15.72% | +3.28% |
Max Drawdown (5Y)Largest decline over 5 years | -28.62% | -18.41% | -10.21% |
Max Drawdown (10Y)Largest decline over 10 years | -36.60% | -27.37% | -9.23% |
Current DrawdownCurrent decline from peak | -1.24% | -4.07% | +2.83% |
Average DrawdownAverage peak-to-trough decline | -11.85% | -11.88% | +0.03% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.35% | 3.93% | +1.42% |
Volatility
DGX vs. JNJ - Volatility Comparison
Quest Diagnostics Incorporated (DGX) has a higher volatility of 10.20% compared to Johnson & Johnson (JNJ) at 8.48%. This indicates that DGX's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DGX | JNJ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.20% | 8.48% | +1.72% |
Volatility (6M)Calculated over the trailing 6-month period | 18.50% | 15.03% | +3.47% |
Volatility (1Y)Calculated over the trailing 1-year period | 23.82% | 18.44% | +5.38% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.35% | 17.46% | +4.89% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.99% | 18.75% | +5.24% |
Dividends
DGX vs. JNJ - Dividend Comparison
DGX's dividend yield for the trailing twelve months is around 1.42%, less than JNJ's 2.04% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DGX Quest Diagnostics Incorporated | 1.42% | 1.82% | 1.96% | 2.02% | 1.66% | 1.40% | 1.85% | 1.99% | 2.34% | 1.83% | 1.72% | 2.07% |
JNJ Johnson & Johnson | 2.04% | 2.48% | 3.40% | 3.00% | 2.52% | 2.45% | 2.53% | 2.57% | 2.74% | 2.38% | 2.73% | 2.87% |
Financials
DGX vs. JNJ - Financials Comparison
This section allows you to compare key financial metrics between Quest Diagnostics Incorporated and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
DGX vs. JNJ - Profitability Comparison
DGX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Quest Diagnostics Incorporated reported a gross profit of 1.03B and revenue of 3.04B. Therefore, the gross margin over that period was 33.8%.
JNJ - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Johnson & Johnson reported a gross profit of 18.50B and revenue of 25.31B. Therefore, the gross margin over that period was 73.1%.
DGX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Quest Diagnostics Incorporated reported an operating income of 459.00M and revenue of 3.04B, resulting in an operating margin of 15.1%.
JNJ - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Johnson & Johnson reported an operating income of 7.17B and revenue of 25.31B, resulting in an operating margin of 28.3%.
DGX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Quest Diagnostics Incorporated reported a net income of 320.00M and revenue of 3.04B, resulting in a net margin of 10.5%.
JNJ - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Johnson & Johnson reported a net income of 5.53B and revenue of 25.31B, resulting in a net margin of 21.9%.
Frequently Asked Questions
DGX and JNJ have a correlation of 0.39, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
DGX has higher volatility (10.20%) compared to JNJ (8.48%). In terms of maximum drawdown, DGX dropped -49.46% vs JNJ's -50.67%.
JNJ currently has the higher Sharpe Ratio (3.26 vs 1.76), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for DGX and JNJ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer